SCHEMBL30936619

SCHEMBL30936619

CNc1ccccc1NS(=O)(=O)c1ccc(S(=O)(=O)N(C)C)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCOLN2 Q8IZK6 1/20 0.51
KEAP1 Q14145 1/20 0.49
NFE2L2 Q16236 1/20 0.49
LMNA P02545 4/20 0.49
ALDH1A1 P00352 3/20 0.49
MAPT P10636 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
USP2 O75604 1/20 0.49
POLB P06746 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
NOD2 Q9HC29 1/20 0.49
TSHR P16473 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MEN1 O00255 1/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
SLC40A1 Q9NP59 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29978580 0.83 KEAP1 (0.51) MCOLN2KEAP1NFE2L2LMNAALDH1A1
SCHEMBL23043640 0.83 MCOLN2 (0.50) MCOLN2KEAP1NFE2L2LMNAALDH1A1
SCHEMBL29979016 0.83 MCOLN2 (0.50) MCOLN2KEAP1NFE2L2LMNAALDH1A1
SCHEMBL23057210 0.83 KEAP1 (0.51) MCOLN2KEAP1NFE2L2LMNAALDH1A1
SCHEMBL30936705 0.81 TSHR (0.50) MCOLN2KEAP1NFE2L2LMNAALDH1A1
SCHEMBL23057078 0.80 KMT2A (0.50) MCOLN2KEAP1NFE2L2LMNAALDH1A1
SCHEMBL23057287 0.80 LMNA (0.71) MCOLN2KEAP1NFE2L2LMNAALDH1A1
SCHEMBL29978300 0.80 KMT2A (0.50) MCOLN2KEAP1NFE2L2LMNAALDH1A1
SCHEMBL29978675 0.80 ALDH1A1 (0.64) MCOLN2LMNAALDH1A1MAPTPOLB
SCHEMBL10143537 0.80 ALDH1A1 (0.71) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof NINE SQUARE THERAPEUTICS CORPORATION (US) 2025-11-06 US disclosed
EP-4608389-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF Nine Square Therapeutics Corporation (US) 2025-09-03 EP disclosed
WO-2024092235-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF NINE SQUARE THERAPEUTICS CORPORATION (US) 2024-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof TRPM2, TRPM6, TRPM5 MCOLN2 19/4885KEAP1 252/4885NFE2L2 520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.